Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a Case Series.

18F-DOPA 68Ga-DOTATOC cardiac imaging cardiac magnetic resonance cardiac metastasis echocardiography neuroendocrine positron emission tomography

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
09 May 2022
Historique:
received: 28 03 2022
revised: 05 05 2022
accepted: 07 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

With the increasing availability of high-performance medical imaging for the management of patients with neuroendocrine tumors (NETs), a progressive growth of asymptomatic and incidentally detected cardiac metastases (CMs) has been observed in the recent years. In clinical practice, CMs of NENs are often incidentally detected by whole-body

Identifiants

pubmed: 35626337
pii: diagnostics12051182
doi: 10.3390/diagnostics12051182
pmc: PMC9139778
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Br J Surg. 2010 May;97(5):691-7
pubmed: 20225244
J Am Coll Cardiol. 2002 Oct 2;40(7):1328-32
pubmed: 12383582
Curr Cardiol Rep. 2019 Jul 31;21(9):103
pubmed: 31367849
Int J Cardiol. 2016 Jan 15;203:474-81
pubmed: 26551882
Int J Cardiol. 2014 Apr 15;173(1):29-32
pubmed: 24636550
Neuroendocrinology. 2016;103(2):172-85
pubmed: 26731013
JACC Cardiovasc Imaging. 2020 May;13(5):1270-1275
pubmed: 31607659
Clin Endocrinol (Oxf). 2021 Oct;95(4):595-605
pubmed: 34018606
Endocrine. 2014 Sep;47(1):5-6
pubmed: 24965229
Curr Cardiovasc Imaging Rep. 2014;7:9281
pubmed: 25018846
J Am Heart Assoc. 2016 May 04;5(5):
pubmed: 27146445
Clin Endocrinol (Oxf). 2021 Jan;94(1):66-73
pubmed: 32790887
Acta Radiol. 2014 May;55(4):389-98
pubmed: 23928010
Int J Cardiovasc Imaging. 2017 Jun;33(6):879-888
pubmed: 28138817
Neuroendocrinology. 2021;111(10):907-924
pubmed: 32717739
Curr Treat Options Oncol. 2019 Jun 27;20(8):66
pubmed: 31250250
J Nucl Med. 2016 Dec;57(12):1949-1956
pubmed: 27811124
Semin Nucl Med. 2021 Sep;51(5):519-528
pubmed: 33838874
JAMA Oncol. 2017 Oct 01;3(10):1335-1342
pubmed: 28448665
PLoS One. 2014 Nov 14;9(11):e112278
pubmed: 25397775
Nucl Med Commun. 2019 Oct;40(10):1081-1085
pubmed: 31365503
Neuroendocrinology. 2010;91(4):326-32
pubmed: 20453466
J Nucl Med. 2019 Oct;60(10):1340-1346
pubmed: 31123099
Circulation. 2007 Nov 6;116(19):2216-33
pubmed: 17959655
Lung Cancer. 2002 Sep;37(3):235-40
pubmed: 12234691

Auteurs

Soraya El Ghannudi (S)

Nuclear Medicine, Institut de Cancérologie de Strasbourg Europe (ICANS), University Hospitals of Strasbourg, 67093 Strasbourg, France.
Department of Radiology, University Hospitals of Strasbourg, 67098 Strasbourg, France.

Eric Ouvrard (E)

Nuclear Medicine, Institut de Cancérologie de Strasbourg Europe (ICANS), University Hospitals of Strasbourg, 67093 Strasbourg, France.

Nidaa Mikail (N)

Nuclear Medicine, ENETS Centre of Excellence, Beaujon Hospital (APHP), 92110 Clichy, France.

Benjamin Leroy Freschini (B)

Nuclear Medicine, Institut de Cancérologie de Strasbourg Europe (ICANS), University Hospitals of Strasbourg, 67093 Strasbourg, France.

Thomas H Schindler (TH)

Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University, St. Louis, MO 63110, USA.

Alessio Imperiale (A)

Nuclear Medicine, Institut de Cancérologie de Strasbourg Europe (ICANS), University Hospitals of Strasbourg, 67093 Strasbourg, France.
Molecular Imaging-DRHIM, IPHC, UMR 7178, CNRS/Unistra, 67093 Strasbourg, France.

Classifications MeSH